
Our Mission
The HPTN develops and evaluates cutting-edge biomedical, behavioral, and structural interventions to reduce the transmission of HIV.
Innovative, transformative, and impactful
23
Active Studies
55
Study Sites
13
Countries
538
Publications
Our Research Agenda
The HPTN research agenda focuses on four strategies:
- Long-acting antiretroviral (ARV) agents for pre-exposure prophylaxis (PrEP)
- Multipurpose prevention technologies (MPTs)
- Broadly neutralizing antibodies (bnAbs)
- Integrated strategies for HIV prevention

Happening at HPTN
HPTN at CROI 2025
HPTN researchers presented 11 abstracts (seven orals and four posters) at the 2025 Conference on Retroviruses and Opportunistic Infections (CROI) in San Francisco.
Read more
Fostering the next era of researchers
HPTN Scholars Program
The HPTN Scholars Program seeks to provide scholar recipients with the knowledge, skills, and connections to further their careers as independent investigators in the HIV prevention research field.
Learn More